Pediatrix Medical (MD) Short-term Investments (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Short-term Investments data on file, last reported at $123.2 million in Q1 2026.

• Quarterly Short-term Investments rose 2.49% year-over-year to $123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.2 million (up 2.49% YoY) and the FY2025 annual result came in at $124.5 million, up 4.99% from the prior year.
• Short-term Investments retreated to $123.2 million in Q1 2026 per MD's latest filing, from $124.5 million in the prior quarter.
• Across five years, Short-term Investments topped out at $124.5 million in Q4 2025 and bottomed at $89.6 million in Q1 2022.
• The 5-year median for Short-term Investments is $107.5 million (2024), against an average of $108.3 million.
• The widest annual swing landed in 2022, when Short-term Investments retreated 11.14%; it then rose 15.54% in 2024.
• Tracing MD's Short-term Investments over 5 years: stood at $93.2 million in 2022, then gained by 12.06% to $104.5 million in 2023, then rose by 13.48% to $118.6 million in 2024, then advanced by 4.99% to $124.5 million in 2025, then retreated by 1.03% to $123.2 million in 2026.
• Per Business Quant, the three latest MD Short-term Investments figures stand at $123.2 million (Q1 2026), $124.5 million (Q4 2025), and $123.0 million (Q3 2025).

Peer Comparison